Free Trial
NASDAQ:MOTS

Motus GI (MOTS) Stock Price, News & Analysis

Motus GI logo
$0.0003 0.00 (0.00%)
As of 07/7/2025

About Motus GI Stock (NASDAQ:MOTS)

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.00
$0.08
Volume
N/A
Average Volume
4,274 shs
Market Capitalization
$1.73 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MOTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter.

MOTS Stock News Headlines

MOTS Motus GI Holdings, Inc. - Seeking Alpha
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

MOTS Stock Analysis - Frequently Asked Questions

Motus GI's stock was trading at $0.0002 at the start of the year. Since then, MOTS stock has increased by 50.0% and is now trading at $0.0003.

Motus GI Holdings, Inc. (NASDAQ:MOTS) issued its quarterly earnings data on Friday, November, 12th. The company reported ($30.00) earnings per share for the quarter, meeting the consensus estimate of ($30.00). The firm had revenue of $0.14 million for the quarter, compared to analyst estimates of $0.12 million.

Motus GI's stock reverse split on Thursday, November 2nd 2023.The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Motus GI (MOTS) raised $21 million in an IPO on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Piper Jaffray acted as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Motus GI investors own include Inovio Pharmaceuticals (INO), NIO (NIO), Tesla (TSLA), Bionano Genomics (BNGO), Acasti Pharma (ACST) and Pfizer (PFE).

Company Calendar

Last Earnings
11/12/2021
Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:MOTS
CIK
1686850
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$319 thousand
Price / Cash Flow
N/A
Book Value
$1.74 per share
Price / Book
0.00

Miscellaneous

Free Float
5,749,000
Market Cap
$1.73 thousand
Optionable
Not Optionable
Beta
1.02
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:MOTS) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners